Endo Tools Therapeutics has secured FDA 510(k) clearance for its next-generation endomina® EZFuse system—marking a meaningful step in the evolution of endoscopic suturing from technically demanding procedures toward streamlined, scalable workflows.
The core shift isn’t just incremental device improvement—it’s operational. By enabling up to 50% reduction in procedure time through a simplified, single-movement suturing mechanism, EZFuse directly targets one of endoscopy’s biggest bottlenecks: time, complexity, and staff burden.This positions endoscopic suturing not just as a clinical capability, but as a throughput and efficiency lever for GI practices and ASCs—unlocking higher case volumes, improved scheduling flexibility, and reduced procedural fatigue.